Immunovant (IMVT) had the highest return between October 4, 2022 and October 21, 2022 by a mid-cap US stock, returning 48.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunovant (IMVT) | 10/4/2022 - 10/21/2022 | 48.9% |
Viking Therapeutics (VKTX) | 10/4/2022 - 10/21/2022 | 46.95% |
Roivant Sciences (ROIV) | 10/4/2022 - 10/21/2022 | 32.14% |
CVR Energy (CVI) | 10/4/2022 - 10/21/2022 | 32.03% |
Enerpac Tool (EPAC) | 10/4/2022 - 10/21/2022 | 31.65% |
Transocean (RIG) | 10/4/2022 - 10/21/2022 | 29.14% |
Kingsoft Cloud Holdings (KC) | 10/4/2022 - 10/21/2022 | 26.26% |
Tidewater (TDW) | 10/4/2022 - 10/21/2022 | 25.19% |
Torm PLC Class A (TRMD) | 10/4/2022 - 10/21/2022 | 24.71% |
NOV (NOV) | 10/4/2022 - 10/21/2022 | 24.41% |
Akero Therapeutics (AKRO) | 10/4/2022 - 10/21/2022 | 24.39% |
Vista Oil Gas ADR (VIST) | 10/4/2022 - 10/21/2022 | 22.35% |
Warrior Met Coal (HCC) | 10/4/2022 - 10/21/2022 | 21.84% |
Matador Resources (MTDR) | 10/4/2022 - 10/21/2022 | 20.93% |
O-I Glass (OI) | 10/4/2022 - 10/21/2022 | 20.44% |
Boston Beer (SAM) | 10/4/2022 - 10/21/2022 | 20.22% |
Washington Federal (WAFD) | 10/4/2022 - 10/21/2022 | 19.66% |
VSE (VSEC) | 10/4/2022 - 10/21/2022 | 19.11% |
Sitio Royalties (STR) | 10/4/2022 - 10/21/2022 | 18.9% |
Cactus (WHD) | 10/4/2022 - 10/21/2022 | 18% |
Cellebrite DI (CLBT) | 10/4/2022 - 10/21/2022 | 17.82% |
Murphy Oil (MUR) | 10/4/2022 - 10/21/2022 | 17.81% |
Advantage Solutions (ADVWW) | 10/4/2022 - 10/21/2022 | 17.59% |
Kymera Therapeutics (KYMR) | 10/4/2022 - 10/21/2022 | 17.43% |
Genworth Financial (GNW) | 10/4/2022 - 10/21/2022 | 17.41% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
